微信公众号
News Center
JNCC Major Announcement! Academician He Jie’s Team Releases the Latest Cancer Data in China
Mar 29,2022
Source:
Cancer incidence in China in 2016
Basic Information
New cases: 4.064 million
Age-standardized incidence rate: 186.46 per 100,000
Higher in males than females (207.03 per 100,000 vs 168.14 per 100,000)
Gender Differences
All age groups: Males Number of deaths Higher than females
Higher female mortality rates: gallbladder cancer, thyroid cancer
Higher male mortality rates: all other cancer types
Age Differences
Higher in males: ages 0-14 and over 60
Higher in females: ages 15-59
Highest mortality rate: ages 60-79
Regional Differences
Overall Higher in rural areas than urban areas (106.1 per 100,000 vs 102.8 per 100,000)
Higher in urban areas: lung cancer, colorectal cancer, breast cancer, prostate cancer
Higher in rural areas: liver cancer, stomach cancer, esophageal cancer, cervical cancer
Cancer mortality in China in 2016
Basic Information
Total deaths: 2.414 million
Age-standardized mortality rate: 105.19 per 100,000
Higher in males than females (138.14 per 100,000 vs 73.95 per 100,000)
Gender Differences
All age groups: male deaths higher than female deaths
Higher female mortality rates: gallbladder cancer, thyroid cancer
Higher male mortality rates: all other cancer types
Age Differences
Higher in males: ages 0-14 and over 60
Higher in females: ages 15-59
Highest mortality rate: ages 60-79
Regional Differences
Overall Higher in rural areas than urban areas (106.1 per 100,000 vs 102.8 per 100,000)
Higher in urban areas: lung cancer, colorectal cancer, breast cancer, prostate cancer
Higher in rural areas: liver cancer, stomach cancer, esophageal cancer, cervical cancer
Trends in cancer incidence and mortality in China from 2000 to 2016
Incidence Trends
Increasing:
Males: prostate cancer, colorectal cancer, leukemia, brain tumors, pancreatic cancer, and bladder cancer
Females: thyroid cancer, cervical cancer, uterine cancer, breast cancer, brain tumors, lung cancer, colorectal cancer
Decreasing:
Both males and females: esophageal cancer, stomach cancer, liver cancer
Mortality Trends
Increasing:
Males: prostate cancer, colorectal cancer, pancreatic cancer, leukemia
Females: cervical cancer, thyroid cancer, breast cancer
Decreasing:
Both males and females: esophageal cancer, stomach cancer, liver cancer, lung cancer
Trends in incidence and mortality of some cancers in males and females from 2000 to 2016. A: male incidence; B: female incidence; C: male mortality; D: female mortality.
Summary
Incidence Situation
- Overall cancer in China Crude incidence rate Continues to rise , reflecting the heavy actual cancer burden in China;
- Top incidence Males: lung cancer; females: breast cancer;
- Incidence rate Higher in urban areas than rural areas ;
- Traditionally high-incidence cancers in China Esophageal cancer, stomach cancer, liver cancer Show a continuing declining trend, but the disease burden remains heavy;
- Cancers common in developed countries such as colorectal cancer, breast cancer, thyroid cancer, prostate cancer show a continuing rise rising
trend, posing a severe prevention and control challenge.
- Mortality Situation Crude cancer mortality rate in China Still shows a rise rising trend, but after adjusting for population age structure, standardized mortality rate declining Shows a
- declining trend, reflecting preliminary achievements in comprehensive cancer prevention and control in recent years;
- Top cause of death:
- Lung cancer for both males and females; Mortality rate higher in rural areas than urban areas; Traditionally high-incidence and poor prognosis cancers in China such as esophageal cancer, stomach cancer, liver cancer , but the mortality rate of cervical cancer is still on the rise;
- Common in developed countries colorectal cancer, breast cancer, thyroid cancer, prostate cancer and other tumors show a continuous increase trend.
Source: JNCC Cancer Science Progress
Contact Us
Consultation phone: 400 000 8876
Recruitment service: pingping@calt-bio.com
Business cooperation: pingping@calt-bio.com
Company address: Building A8, Huizhi Technology Park, High-tech Industrial Park, Nanjing